In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma

European Journal of Radiology

Volumn 53, Issue 3 SPEC. ISS., 2005, Pages 506-513

  Bourne, Roger M ^a   Stanwell, Peter ^a   Stretch, Jonathan R ^b   Scolyer, Richard A ^b   Thompson, John F ^b   Mountford, Carolyn E ^a   Lean, Cynthia L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cancer; Lymph nodes; Magnetic resonance spectroscopy; Melanoma; Metastases; Skin

Indexed keywords

AMINO ACIDS; BIOMARKERS; BIOPSY; PATHOLOGY; PATIENT TREATMENT; RADIOLOGY; TUMORS;

BENIGN TISSUES; CHOLINE; LYMPH NODES; METASTATIC MELANOMA;

MAGNETIC RESONANCE SPECTROSCOPY;

ALANINE; AMINO ACID; BIOLOGICAL MARKER; CHOLINE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; LYSINE; TAURINE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CASE REPORT; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHOMA; MALE; MELANOMA; METABOLITE; METASTASIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SKIN BIOPSY; SKIN DEFECT;

EID: 14644396133     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2004.03.016     Document Type: Article

References (27)

1. Serraino D., Fratino L., Gianni W., et al. Epidemiological aspects of cutaneous malignant melanoma (review). Oncol. Reports. 5(4):1998;905-909
2. Lean C, Bourne R, Thompson J, et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens. Melanoma Res. 2003;13:259-61.
3. Querleux B., Jolivet O., Bittoun J. In vivo proton magnetic resonance spectroscopy in human skin. Curr. Probl. Dermatol. 26:1998;12-19
4. Kim Y.H., Orenberg E.K., Faull K.F., Wade-Jardetzky N.G., Jardetzky O. 1 H NMR spectroscopy: an approach to evaluation of diseased skin in vivo. J. Invest. Dermatol. 92(2):1989;210-216
5. Davidorf F., Chambers R., Gresak P. False-positive magnetic-resonance- imaging of a metastatic carcinoma simulating a malignant-melanoma. Ann. Ophthalmol. 24:1992;391-394
6. Bloom P., Ferris J., Laidlaw D., Goddard P. Magnetic-resonance-imaging- diverse appearances of uveal malignant melanomas. Arch. Ophthalmol. 110:1992;1105-1111
7. Ferris J., Bloom P., Goddard P., Collins C. Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic-resonance image. Br. J. Ophthalmol. 77:1993;297-301
8. Liu K.R., Peyman G.A., Mafee M.F., Yu D.Y. False positive magnetic-resonance imaging of a choroidal nevus simulating choroidal melanoma. Int. Ophthalmol. 13:1989;265-268
9. Lemke A.J., Hosten N., Wiegel T., et al. Intraocular metastases: differential diagnosis from uveal melanomas with high-resolution MRI using a surface coil. Eur. Radiol. 11(12):2001;2593-2601
10. Takahashi M., Kohda H. Diagnostic utility of magnetic resonance imaging in malignant melanoma. J. Am. Acad. Dermatol. 27(1):1992;51-54
11. Hawnaur J.M., Dobson M.J., Zhu X.P., Watson Y. Skin: MR imaging findings at middle field strength. Radiology. 201(3):1996;868-872
12. Ak I., Stokkel M.P., Bergman W., Pauwels E.K. Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment. Eur. J. Nucl. Med. 27(4):2000;447-458
13. Lean CL, Somorjai RL, Smith ICP, Russell PR, Mountford CE. In: Webb G, editor. Accurate diagnosis and prognosis of human cancers by proton MRS and a three stage classification strategy. Ann Reports NMR Spectrosc: Academic Press; 2002. p. 71-111.
14. Danielsen ER, Ross BD. Magnetic resonance spectroscopy: diagnosis of neurological diseases. New York: Marcel Dekker; 1999.
15. Kurhanewicz J., Vigneron D.B., Males R.G., Swanson M.G., Yu K.K., Hricak H. The prostate: MR imaging and spectroscopy. Present and future. Radiol. Clin. North Am. 38(1):2000;115-138. viii-ix
16. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 508:1987;333-348
17. Tran T-KC, Vigneron DB, Sailasuta N, et al. Improving clinical MRSI with very selective saturation pulses to reduce chemical shift errors and conform press selection. In: Proceedings of the Eighth Annual Meeting of the ISMRM, Denver, USA; 2000. p. 366.
18. Tran T.-K.C., Vigneron D.B., Sailasuta N., et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn. Reson. Med. 43(1):2000;23-33
19. Haase A., Frahm J., Hanicke W., Matthaei D. 1 H NMR chemical shift selective (chess) imaging. Phys. Med. Biol. 30(4):1985;341-344
20. Bourne R., Dzendrowskyj T., Mountford C. Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS. NMR Biomed. 16:2003;1-6
21. Braun S, Kalinowski H-O, Berger S. 150 and more basic NMR experiments: a practical course, 2nd ed. Weinheim: Wiley-VCH; 1998.
22. Zemtsov A., Lorig R., Ng Tc Xue M., et al. Magnetic-resonance-imaging of cutaneous neoplasms-clinicopathological correlation. J. Dermatol. Surg. Oncol. 17:1991;416-422
23. Isiklar I., Leeds N., Fuller G., Kumar A. Intracranial metastatic melanoma-correlation between MR-imaging characteristics and melanin content. Am. J. Roentgenol. 165:1995;1503-1512
24. Morvan D., Demidem A., Papon J., De Latour M., Madelmont J.C. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res. 62(6):2002;1890-1897
25. Dobrota D., Pec J., Pec M., et al. Study of malignant melanoma using 1 H-nuclear magnetic resonance spectroscopy. Bratisl. Lek. Listy. 96(3):1995;134-136
26. El-Sayed S., Bezabeh T., Odlum O., et al. An ex vivo study exploring the diagnostic potential of 1 H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck. 24(8):2002;766-772
27. Crotty K., Scolyer R., Li L., Palmer A., Wang L., McCarthy S. Spitz naevus versus spitzoid melanoma: when and how can they be distinguished? Pathology (Phila). 34:2002;6-12